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Abstract: Acute myocardial infarction is a highly prevalent cardiovascular disease in 
Taiwan. Among several etiological risk factors, obesity and inflammation are strongly 
associated with the frequency of hypertension, cardiovascular disease, diabetes, and 
myocardial infarction. To discriminate obesity- and inflammation-related genes and the 
onset of acute myocardial infarction (AMI), a case-control study was conducted to 
investigate the association of the -308G/A polymorphisms of tumor necrosis factor   
(TNF)-α and the C825T polymorphism of guanidine nucleotide binding protein 3 (GNB3) 
with the onset of AMI among Taiwanese cohorts. A total of 103 AMI patients and 163 
matched normal control samples were enrolled in the present study. The genomic DNA 
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was extracted and subjected into polymerase chain reaction-based restriction fragment 
length polymorphism (PCR-RFLP) analysis. An association between the A homozygosity 
of the TNF-α-308G/A polymorphism and the onset of AMI was observed among the male 
subjects (p = 0.026; Spearman index = 0.200, p = 0.008). An association between the T 
homozygosity of GNB3 C825T polymorphism and obesity was also observed (Fisher’s 
exact, p = 0.009). The TT genotype has a protective effect against acquiring AMI among 
the obese female population in Taiwan (Fisher’s exact, p = 0.032). In conclusion,   
TNF-α-308G/A and the GNB3 C825T polymorphisms are associated with obesity and AMI 
in the Taiwanese population. 
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1. Introduction  
Acute myocardial infarction (AMI) is one of the leading causes of death worldwide. AMI has a high 
prevalence in Taiwanese cohorts, especially the elderly [1]. However, the age of AMI onset has 
decreased because of environmental risk factors and genetic polymorphisms [2].  
Tumor necrosis factor-α (TNF-α), a key pro-inflammatory factor, has been linked to several human 
diseases. The -308G/A polymorphism in the promoter region of TNF-α is associated with its 
expression and effects, such as in lipid metabolism, insulin resistance, and endothelial function in 
cardiovascular disease [3]. A higher frequency of carriers of the A allele is observed in patients with 
unstable angina. A more striking association between A allele carriage frequency and unstable angina 
is found in patients with a body mass index (BMI) ≤ 27 (p = 0.012; odds ratio = 3.0) [4]. The 
association between the A allele carriage frequency and the development of atherosclerosis, as well as 
the presence of family history of coronary heart disease is also observed [5]. Antonicelli et al. 
demonstrated the higher frequency of the TNF-α-308AA+AG genotype among ST-elevation AMI 
patients compared with the non-ST-elevation AMI patients and normal individuals [6].  
G-proteins are essential partners of the seven transmembrane receptors for the activation or 
inhibition of intracellular signaling cascades. Most vasoactive or growth stimulating factors 
communicate via G proteins in virtually all cardiovascular tissues [7]. Recently, a C825T 
polymorphism has been described in exon 10 of the β3 subunit of G protein (GNB3) [8]. The T allele 
results in the expression of a splicing variant with a deletion of 41 amino acids, including one 
tryptophan–aspartic acid (WD) domain [9]. The splicing variant is active and the cellular response 
increases [9]. Emerging reports have demonstrated that the C825T polymorphism of GNB3 is 
associated with different human diseases, such as hypertension [10], cardiovascular diseases [10,11], 
and ischemic stroke [12] According to a previous study, the C825T polymorphism of GNB3,  
T-homozygosity was found to be significantly more common among female myocardial infarction (MI) 
fatalities than the female control group (24% versus 7%; Relative Risk 2.29). The investigators 
concluded that the C825T polymorphism may play a role in the development of MI, at least among 
females [13]. The association of the T allele of the GNB3 C825T polymorphism with arterial 
hypertension has been confirmed in smaller cohorts [8,14,15]. Some divergent results have also been Int. J. Mol. Sci. 2012, 13 1848 
 
 
obtained [16,17]. Several studies have also shown that young 825T allele carriers are predisposed to 
obesity, and this association could be confirmed across different ethnicities, including young Germans, 
Chinese, and Black Africans [18]. In the present study, we aim to investigate the association between 
the -308G/A polymorphisms of TNF-α and the C825T polymorphism of GNB3 in terms of the onset of 
AMI among Taiwanese cohorts.  
2. Results 
The genetic frequencies of the TNF-α-308G/A and the GNB3 C825T polymorphisms among the 
different subjects are shown in Table 1. A significantly reduced frequency of the T homozygote of the 
GNB3 C825T polymorphism was observed in the BMI ≥ 27 subgroup (p = 0.009; Spearman index = 
−0.381, p = 0.003; OR = 0.548, 95% CI = 0.331–0.910). However, no differences were observed in the 
genetic frequency distribution of the  TNF-α-308G/A polymorphism when the AMI patients were 
compared with the normal subjects (group IIA).  
Table 1. The allele frequency distribution of Tumor necrosis factor-α (TNF-α) -308G/A 
and guanidine nucleotide binding protein 3 (GNB3) C825T polymorphism. 
TGF -308  G/A  p value  Spearman 
Colleration 
O.R.  
(95%C.I.) 
AA vs. GG+GA         
BMI >= 27  AMI/IIA       
 GG  65%/54%  0.063  0.323  ND 
 GA  20%/46%    (0.013)   
 AA  15%/0%       
BMI < 27  GG 72%/69%  1.0  0.013  1.124 
 GA  23%/27%    (0.087)  (0.260–4.855) 
 AA  5%/4%       
GNB C825T         
TT vs. CC+CT         
BMI >= 27  AMI/IIA       
  CC 10%/5%  0.009 **  −0.381 0.548 
 CT  45%/13%    (0.003)  (0.331–0.910) 
 TT  45%/82%       
BMI < 27         
 CC  13%/21%  0.908  0.022  1.048 
 CT  37%/31%    (0.783)  (0.753–1.048) 
 TT  50%/48%       
O.R.: odd ratio; ND: not determine; ** p < 0.001. 
The T allele carriage is beneficial for avoiding the onset of AMI among obese women in Taiwanese 
cohorts (Table 2, p = 0.032).  Int. J. Mol. Sci. 2012, 13 1849 
 
 
Table 2. The allele frequency distribution of GNB3 C825T polymorphism for advanced 
analyses in relation to gender. 
   p value  Spearman 
Correlation 
O.R. 
(95%C.I.) 
BMI >= 27, female         
 AMI/IIA       
TT 0%/89%  0.032  *  −0.667 ND 
CC+CT 100%/11%    (0.001)   
BMI >= 27, male         
 AMI/IIA       
TT 50%/76%  0.108  −0.272 0.658 
CC+CT 50%/24%    (0.094)    (0.390–1.104) 
O.R.: odd ratio, ND: not determine; * p < 0.05. 
A high frequency of T allele carriage was also found among the AMI patients and the healthy 
control subjects. The T homozygosity acts as a predisposing factor for obesity (Table 3, χ
2 = 7.656,  
p  =  0.006; Spearman index  = 0.19, p  =  0.006; OR  =  1.437, 95% CI  = 1.135–1.818). The T 
homozygosity of the GNB3 C825T polymorphism results in a transcriptional truncated variant, and 
through the signal-enhancing ability of the G protein, it modulates adipogenesis and obesity risk. 
Furthermore, it is also associated with essential hypertension. However, a correlation between the T 
homozygote and the onset of AMI was not observed among Taiwanese cohorts, although a protective 
effect was observed within the obese female population. The results still need further confirmation via 
large-scale gene-associated studies within the Taiwanese cohorts. The controversial results might 
provide other clues as to whether this polymorphism does not directly affect the onset of AMI whether 
in males or females. The results might also modulate the AMI risk through the unknown mechanism, 
and this characteristic might differ among different ethnic groups.  
Table 3. The allele frequency distribution of GNB3 C825T polymorphism for advanced 
analyses in relation to obesity. 
   p value  Spearman 
Correlation 
O.R. 
(95%C.I.) 
  BMI > 27/BMI < 27     
TT  70%/48%  0.006 **  0.19  1.437 
CT+CC  30%/52%   (0.006) **  (1.135–1.181) 
O.R.: odd ratio; ** p < 0.001. 
For the TNF-α-308G/A polymorphism, we referred to the analyses that the association of gender 
might have an influence upon the AMI onset in advance because obesity might not be involved. An 
association between the A allele homozygosity of TNF-α-308G/A polymorphism with AMI within the 
male population was confirmed, but not in the female cohorts (Table 4, χ
2 = 4.948, p = 0.026; 
Spearman index = 0.200, p = 0.008). The G to A substitute of the -308 nucleotide located in the 
promoter region of the TNF-α gene would increase its mRNA transcription level and contribute to the 
elevation of serum TNF-α secretion. The increased pro-inflammatory cytokine may accelerate the 
formation of plaque rupture via the induction of unusual apoptosis activities of the cardiomyocytes, Int. J. Mol. Sci. 2012, 13 1850 
 
 
and modulates the AMI onset risk. Our finding was consistent with the current point of view. The male 
gender is considered a risk factor for the onset of AMI, but the exact genetic basis has not been 
investigated very well. The polymorphisms of inflammatory cytokines might probably be involved in 
this sex difference.  
Table 4. The allele frequency distribution of TNF-α-308G/A polymorphism for advanced 
analyses in relation to gender. 
   p value  Spearman 
Correlation 
O.R. 
(95%C.I.) 
AA vs. GG+GA         
Male AMI/IIA+IIB      
AA 7%/100%  0.026  *  0.2  ND 
GA+GG 93%/0%    (0.008)   
Female          
AA 5%/6%  1.00  −0.016 0.845 
GA+GG 95%/94%    (0.879)  (0.100–7.159) 
O.R.: odd ratio, ND: not determine; * p <0.05. 
3. Materials and methods 
3.1. Patients 
Up to 103 (82 men, 21 women; mean age = 60; obese = 20, non-obese = 83) Taiwanese patients 
with AMI recently registered in the Cardiovascular Disease Study from January 2006 to September 
2006 in the Cardiology Division of Kaohsiung Armed Forces General Hospital or old AMI cases since 
March 1998 were recruited upon their return to the out-patient service of Kaoshiung Military General 
Hospital for their regular physical exams. Obesity was defined as having a BMI ≥ 27. Another group 
of 163 (92 men, 71 women; mean age = 53; obese = 39, non-obese = 124) healthy individuals were 
recruited as the control subjects. Among the control subjects, 109 patients who have no history of AMI 
but have other cardiovascular symptoms were recruited as control group IIA (non-AMI subgroup), 
whereas 54 who have no conventional cardiovascular disease risk factors were designated as control 
group IIB (low conventional risk of CAD subgroup). The conventional risk factors were described in a 
previous report [19]. Informed consent was obtained from each person. The present study was 
approved by the International Review Board, and complied with the Guidelines for Genetic Research 
of Kaohsiung Armed Forces General Hospital.  
3.2. Genotyping 
Peripheral blood (4 mL) was collected from each subject into vacuum tubes containing 50 mmol/L 
ethylenediamine tetraacetic acid. Genomic DNA was isolated with a NucleoSpin
® Blood Genomic 
DNA kit (Macherey-Nagel, Duren, Germany). The A and G alleles at position -308 in the promoter 
region of the TNF-α gene were identified using the amplification refractory mutation system 
polymerase chain reaction (ARMS-PCR) methodology as previously described, with minor 
modifications [20]. A total of 100 ng of genomic DNA was used in each ARMS-PCR reaction. The Int. J. Mol. Sci. 2012, 13 1851 
 
 
PCR primer sequences were as follows: Generic primer, TNFA-R (antisense): 5’-tctcggtttcttctccatcg-3’, 
Primer specific for G allele, TNFA-F1 (sense): 5’-ataggttttgaggggcatgg-3’, Primer specific for A allele, 
TNFA-F2 (sense): 5’-aataggttttgaggggcatga-3’. The 20 µL basic PCR reaction mixture contained   
100 ng of DNA, 10 pmol of each primer, 0.25 mmol/L of premixed deoxynucleoside triphosphate,  
0.5 mmol/L, and 1 U YEA Taq polymerase (Yeastern Biotech, Taipei, Taiwan). The PCR conditions 
for the TNF-α-308G/A SNP amplification comprised two major thermal cycling procedures: an initial 
denaturation at 95 °C for 1 min; 10 cycles of denaturation at 95 °C for 15 s, annealing at 63 °C for  
45 s, extension at 72 °C for 35 s; 25 cycles of denaturation at 95 °C for 20 s, annealing at 59 °C for  
45 s, extension at 72 °C for 45 s, and a final extension at 72 °C for 5 min. The resulting amplified 
ARMS-PCR product was 184 bp (Figure 1A). The GNB3 C825T polymorphism was determined by 
PCR-RFLP analysis. The primers used in the PCR were those described by Siffert et al. [9]. The PCR 
conditions comprised initial denaturation at 94 °C for 5 min; 35 cycles of denaturation at 94 °C for  
15 s, annealing at 60 °C for 30 s, extension at 72 °C for 30 s, and a final extension at 72 °C for 8 min. 
The 268 bp PCR product was digested with BsaJI for 2–3 h at 37 °C. Thus, the BsaJI restriction site 
would be destroyed if the PCR product included a C to T substitution, whereas the C allele generated 
two fragments, 152 and 116 bp (Figure 1B). The amplified DNA or enzyme-restricted fragments were 
separated using 2% Amresco
® Agarose I™ agarose (Solon Ind., Solon, OH, USA), and then stained 
with 0.5 µg/mL ethidium bromide solution, and visualized by Stratagene Eagle Eyes
® II UV 
transilluminator (Stratagene, La Jolla, CA, USA). The gel image was recorded with a digital gel 
documentation system. To confirm the accuracy of genotyping by this method, we randomly selected 
10% DNA samples and subjected them to direct DNA sequencing. In each instance, the genotype 
determined by the allele-specific PCR assay system or PCR-RFLP was identical to the samples 
determined by the confirmatory methods. The genotype of each polymorphism was confirmed by at 
least two well-trained laboratory technicians. To further confirm the PCR-RFLP results, directed DNA 
sequence analysis using forward and reverse primers was also performed (Figure 2). 
Figure 1. The polymorphism of TNF-α-308G/A and GNB3 C825T. (A) the 184 bp genotype 
specific PCR products of TNF-α-308G/A polymorphism were amplified by using ARMS-
PCR as described in Methods. Two independent PCR reactions for allele-specific 
amplification of each clinical sample were performed and separated by gel electrophoresis. 
The gel image revealed three typical genotypes of this polymorphism; (B) The patterns of 
GNB3 C825T polymorphism after digested with BsajI restriction enzyme were shown. This 
pattern consisted of CT: 268 bp, 152 bp, and 116 bp digested fragments; CC: 152 bp and 116 
bp digested fragments; TT: an indigested 268bp DNA fragment. M: 100 bp DNA maker. 
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Figure 2. DNA sequence analysis of polymorphism of TNF-α and GNB3. Amplicons of 
TNF-α-308G/A (left panel) and GNB3 C825T were subjected into directed DNA sequence 
analysis using reverse (TNF-α-308G/A) and forward (GNB3 C825T) primers. The polymer 
sites were indicated with arrows. 
 
3.3. Statistical Analysis 
The experimental data on the gene polymorphisms were converted into categorical variables and 
compared with a χ
2 test, Fisher’s exact test, and Spearman’s correlation test to distinguish the 
significance of the variation among the subjects. Allele frequencies were estimated through the   
gene-counting method. The χ
2 test was used to identify departure from the Hardy–Weinberg 
equilibrium. Each polymorphism was assessed according to dominant, recessive, and additive genetic 
models. The odds ratio and 95% confidence interval of each genotype conferring to AMI risk were 
also calculated. The statistical significance was defined as having a p value lower than 0.05, and all 
statistical methods were performed using the commercial statistical package software SPSS 13.0 for 
Windows (SPSS, Inc., Chicago, IL, USA). 
4. Discussion 
AMI is a polygenic illness, and its molecular genetic levels have been studied for quite some time. 
Many susceptible gene candidates have been confirmed to be highly associated with the onset and 
prognosis of AMI [21,22]. Even some well-known etiologic risk factors probably have genetic 
backgrounds. The interaction between environmental risk factors and the susceptible gene 
polymorphisms is highly interesting. Hypertension, obesity, and cardiogenic inflammation are the 
common disorders that constitute a major risk factor for cardiovascular diseases, including kidney and Int. J. Mol. Sci. 2012, 13 1853 
 
 
cerebrovascular diseases [23]. Although the underlying molecular mechanisms remain largely elusive, 
recent advances in SNP studies have provided strong evidence that the risk of AMI is   
variable according to interpopulation or intrapopulation, and is largely determined or modulated by 
genetic factors. 
Growing evidence shows that inflammation plays a central role in the pathogenesis of AMI [24]. 
Among the factors that promote inflammation and arterial thrombosis, one of the most important is the 
proinflammatory cytokine TNF-α [25]. The expression of this cytokine is modulated by a 
polymorphism located at nucleotide -308 of the TNF-α promoter gene [26]. There is a significant 
association between the TNF-α-308 polymorphism and the occurrence of ST-elevated myocardial 
infarction (STEMI), which suggests that this polymorphism plays a role in the pathogenesis of cardiac 
ischemic damage [27]. High plasma levels of biochemical ischemic markers have been found among 
AA+AG TNF-α -308 genotype carrier individuals, which shows that they would likely be affected by 
more severe ischemic damage than the rest of the population [6]. Furthermore, the homozygous A 
allele carriage of this polymorphism has been associated with unstable angina [4] and susceptibility to 
plaque formation, in accordance with its mechanisms. Based on these findings, A allele carriage is not 
associated with the risk of CAD or MI in the angiographically examined patients [28]. However, A 
allele carriage is commonly believed to predispose to CAD and MI. In the present study, an association 
between A homozygous allele carriage and the onset of AMI was observed among male Taiwanese 
subjects, which might be independent of obesity. Polymorphisms of proinflammatory cytokines, such 
as IL-6 -174 G > C, have also been associated with acute coronary syndrome (ACS), resulting in 
higher risk of death among elderly ACS male patients [29]. Polymorphism of proinflammatory 
cytokines is more likely to be sex-dependent because of its contribution to the pathogenesis of AMI. 
This hypothesis still needs to be confirmed. According to previous TNF-α-308G/A SNP studies 
performed in Taiwanese cohorts, the A homozygous carriage is seldom detected, only ranging from 
0.37%–1.25%, and it is not associated with hypertension and type II DM [30,31] (The lower frequency 
obtained in the present study was 4.13%, which might also reflect the nature of genetically 
predisposing factors.  
For the genetic variant of the GNB3 gene, Siffert et al. first described a C825T polymorphism in 
exon 10 of the GNB3 gene, which encodes the β3-subunit of G-protein. The 825T allele was found to 
be associated with the expression of a truncated but functionally active splice variant of the β3-subunit, 
an enhanced intracellular signal transduction of G-protein cascade, and an increased risk of 
hypertension [9]. As a result, alterations, such as C to T substitution at nucleotide 825 that affect  
G-protein function or expression may have a strong influence on cellular signaling, consequently 
modulating a wide range of disorders [10,32]. However, arguable results were obtained; most studies 
in Caucasian populations support the idea that the 825T allele increases the risk for hypertension. In 
contrast, studies among Black and East Asian populations show more controversial results [10]. The 
highest frequencies of the 825T allele (up to 80%) are found among old ethnic groups, e.g., Black 
Africans, African Americans, Bushmen, and Australian aborigines. The enhanced G protein activation 
represents a thrifty genotype, which might have facilitated the survival of our ancestors. The 
frequencies of the 825T allele are significantly lower in Asians (approximately 40 to 50%) and 
Caucasians (30%). Excluding the influence on blood pressure control, many studies examined the 
potential association between GNB3 C825T polymorphism and several other phenotypes of clinic traits, Int. J. Mol. Sci. 2012, 13 1854 
 
 
such as obesity [18,32,33], atherosclerosis [11,34], myocardial infarction [35], radial artery 
hypertrophy [36], and diabetes [37]. The widely accepted concept is that the GNB3  825T allele 
carriage results in hypertension. However, limited evidence of its clinical relevance to the onset of 
AMI has been identified. Some phenomena suggest that the GNB3 825T allele carriage might interact 
with the D allele of ACE I/D polymorphism, and probably has a combined effect on MI [35], or is 
associated with the onset of AMI among female Caucasians cohorts. These divisive observations have 
been mentioned in a previous study [38]. In addition,  Hengstenberg  et al. have shown that the 
prevalence of TT genotype did not show any significant difference in female individual in   
population-base survey compared to MI patients [38]. On the other hand, Klintschar et al. have 
demonstrated that T homozygous frequency was higher in female myocardial infarction group 
compared to normal control group, whereas no difference was found in male [39]. In this study, we 
observed that  TT genotype has a protective effect against acquiring AMI among the obese female 
population in Taiwan. These differences may results from distinct ethnic groups. Interestingly, 
homozygous T allele carriage of the GNB3 C825T was found to be quite common within Taiwanese 
population (50%–60%). The homozygous T allele carriage of the GNB3 C825T is associated with 
obesity, but somehow has an opposite effect on the onset of AMI among our studied population.  
5. Conclusions 
Genotyping at the TNF-α and GNB3 loci represents an ideal tool for preventive medicine, in that 
individuals at risk of obesity and AMI can be identified early and their genetic predisposition could be 
counteracted through changes in lifestyle. For individuals with borderline AMI, genotyping can 
facilitate decisions related to medical treatment as a positive test confirms an inherited form of AMI. 
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